Aurelium BioPharma
Aurelium BioPharma Inc., a privately held company, focuses on developing novel diagnostic products in oncology.
The company has developed several diagnostic tests for the detection of breast, ovarian as well as drug-resistant cancers. Aurelium has a strong “drugable” pipeline of novel targets and complimentary diagnostic products that are utilized in its strategic collaborations and out-licensing efforts.